Guwahati, Aug 19 (TIWN) The Gauhati Medical College and Hospital (GMCH) has been selected for the second phase clinical testing of India's indigenously developed coronavirus vaccine, COVAXIN, Assam Health Minister Himanta Biswa Sarma said on Tuesday.

He said the GMCH would provide all-out support for the second phase clinical testing of COVAXIN, which has already shown successful results in phase-one clinical trials.